Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UAB DERMATOLOGY
Birmingham Alabama 35233

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Arkansas

BURKE PHARMACEUTICAL RESEARCH
Bryant Arkansas 72022

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

California

ENCINO RESEARCH CENTER
Encino California 91436

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

DERMATOLOGY RESEARCH ASSOCIATES
Los Angeles California 90045

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

DERMATOLOGY SPECIALISTS, INC
Oceanside California 92056

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

INTEGRATED RESEARCH GROUP, INC
Riverside California 92506

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

SAN LUIS DERMATOLOGY AND LASER CLINIC
San Luis Obispo California 93405

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Connecticut

NEW ENGLAND RESEARCH ASSOCIATES LLC
Trumbull Connecticut 06611

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Florida

Meridien Research
Brooksville Florida 34601

Atopic Dermatitis/Eczema Study

Georgia

Columbus Regional Research Institute
Columbus Georgia 31904

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose Regimens Administered as Monotherapy for Maintaining Treatment Response in Patients with Atopic Dermatitis

Columbus Regional Research Institute
Columbus Georgia 31904

An Open-Label Study of Dupilumab In Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials

Columbus Regional Research Institute
Columbus Georgia 31904

Embarrassed by your eczema or Atopic Dermatitis?

Indiana

DS RESEARCH
New Albany Indiana 47150

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

THE INDIANA CLINICAL TRIALS CENTER
Plainfield Indiana 46168

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Kentucky

DERMRESEARCH
Louisville Kentucky 40217

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

DS RESEARCH
Louisville Kentucky 40241

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Massachusetts

ACTIVMED PRACTICES & RESEARCH, INC
Beverly Massachusetts 01915

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

ActivMed Practices & Research, Inc.
Beverly Massachusetts 01915

Do you or a loved one suffer from Eczema (Atopic Dermatitis)?

TUFTS MEDICAL CENTER
Boston Massachusetts 02111

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Michigan

David Fivenso, MD, Dermatology, PLLC
Ann Arbor Michigan 48103

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

HENRY FORD HOSPITAL
Detroit Michigan 48202

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Minnesota

Clinical Research Institute, MN
Minneapolis Minnesota 55402

888_Atopic Dermatitis Research Study for Adolescents

Missouri

Washington University
Saint Louis Missouri 63110

A Washington University research study seeks female participants.

WASHINGTON UNIVERSITY - DERMATOLOGY
St. Louis Missouri 63141

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

WASHINGTON UNIVERSITY - DERMATOLOGY
St. Louis Missouri 63110

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

New Hampshire

ACTIVMED PRACTICES AND RESEARCH, INC
Portsmouth New Hampshire 03801

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

New Jersey

HASSMAN RESEARCH INSTITUTE, LLC
Berlin New Jersey J 08009

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Psoriasis Treatment Center of Central New Jersey
East Windsor New Jersey 08520

Tralokinumab monotherapy for moderate to severe atopic dermatitis.

New York

Sadick Research Group
New York New York 10075

A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects with Moderate Atopic Dermatitis (Eczema)

Juva Skin and Laser Center
New York New York 10022

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-Resistant Pruritus Associated with Atopic Dermatitis

Sadick Research Group
New York New York 10075

A randomized, double-blind, multi-center, parallel-group, placebo- controlled dose-ranging study to assess the efficacy and safety of nemolizumab (CD14152) in moderate-to-severe atopic dermatitis subjects with severe pruritus receiving topical corticosteroids

Sadick Research Group
New York New York 10075

A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in patients with moderate to severe atopic dermatitis who are candidates for systemic therapy

DERMRESEARCHCENTER OF NEW YORK, INC
Stony Brook New York 11790

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

North Carolina

PMG Research of Charlotte
Charlotte North Carolina 28209

Atopic Dermatitis (Eczema) – Moderate to Severe

DERMATOLOGY CONSULTING SERVICES, PLLC
High Point North Carolina 27262

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

WAKE RESEARCH ASSOCIATES LLC
Raleigh North Carolina 27612

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

WAKE RESEARCH ASSOCIATES LLC
Raleigh North Carolina 27612

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

Wake Research Associates
Raleigh North Carolina 27612

Does your child have atopic dermatitis, also known as eczema?

Ohio

DERMATOLOGISTS OF GREATER COLUMBUS
Bexley Ohio 43209

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

RAPID MEDICAL RESEARCH, INC
Cleveland Ohio 44122

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Oklahoma

CENTRAL SOONER RESEARCH
Norman Oklahoma 73071

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Oregon

OREGON HEALTH & SCIENCE UNIVERSITY
Portland Oregon 97239

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Pennsylvania

Penn State Dermatology
Hershey Pennsylvania 17033

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

PARISH DERMATOLOGY, INC.
Philadephia Pennsylvania 19103

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

PEAK RESEARCH LLC
Upper St. Clair Pennsylvania 15241

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Tennessee